Skip to main content
Watch Insiders
SEPN filings

Corporate insider profile

Daniel D. Long Filing Activity

Latest reported as SVP, Drug Discovery of Septerna, Inc. (SEPN).

Purchase filings
0
Reported companies
1
Net open-market value
-$762,029.19
Latest transaction
Aug 3, 2026

Affiliated corporations

Reported company relationships

SEPNLatest reported

Septerna, Inc.

SVP, Drug Discovery

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 3, 2026Septerna, Inc. (SEPN)SVP, Drug DiscoverySale3,334$34.47$114,920
Jul 1, 2026Septerna, Inc. (SEPN)SVP, Drug DiscoverySale3,333$34.36$114,528
Jun 22, 2026Septerna, Inc. (SEPN)SVP, Drug DiscoverySale15,000$35.51$532,581